Back to People & Entities
SM et of
Organization
1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
Document Mentions (1)
EFTA00506070.pdf
1 mentionEFTA00506070
efficacy, unapproved for immunocompromised and those less than 50 years old • From 2007-2009, lostavax • uptake was extremely low at 3.9% (Langan, SM et of PLOS 2013) Unapproved shingles antiviral, • ASP-2151: Hellcase Inhibitor development officially suspended in 2011 because of toxicity • FY-100:
Sponsored
Connected Entities
No connected entities